IN THE NEWS
|
Dr Anthony Rebuck, Director of Pfizer Clinical Research Unit, said: "As the company discovered more and more new medicine, we needed to do more and more trials…When you increase the number of beds, you increase the size of the labs and the pharmacy that makes the medicine... so eventually, we outgrew ourselves, so we have to move to a place with much more space and more beds available." (Feb 6, 2008)
Dr Anthony Rebuck, Director of Medical Research at Pfizer CRU Singapore, said, “…Our new facility will allow us to undertake more simultaneous clinical trials…and facilitate more rapid introduction of medicines in Asia and around the world.” (Oct 19, 2007)
Its director of medical research Anthony Rebuck said Pfizer's plan was to double the number of volunteers it attracts for its research, to 2,000 people a year. (Oct 19, 2007)
Competitors Hope to Sidestep Rezulin Worries
In more than 5,400 patients tested using Avandia, "there's been absolutely no sign at all" of liver-enzyme elevations, says Anthony Rebuck, who heads up clinical research and development at SmithKline. "The incidence of increases are identical to placebo." (Mar 23, 1999)
New Research Raises Hopes For Improved Asthma Treatment Ten or 15 years from now, there will be several new asthma treatments available, each of which narrowly targets a specific immune molecule important in asthma, predicts Anthony Rebuck, Vice President for Pulmonary Disease and Diabetes Research and Development at SmithKline. (Dec 18, 1998)
"Nasal Continuous Positive Airway Pressure in Pneumocystis Carinii" Pneumonia
Abstract: Continuous positive airway pressure (CPAP) applied with a nasal mask may be a useful method for AUgmenting oxygenation in Pneumocystis carinii pneumonia (PCP) in AIDS patients, say Steven Kesten and Anthony S. Rebuck of Toronto Western Hospital. (Dec 17, 1988)
The Mac Series of Medical and Physiological Simulations - Those who, over the years, contributed most to the development, as authors, were: …Dr Anthony Rebuck. (Nov 25, 2008)
|